Telomerase and idiopathic pulmonary fibrosis

被引:167
|
作者
Armanios, Mary [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
Dyskeratosis congenita; Interstitial lung disease; Aplastic anemia; Liver cirrhosis; Emphysema; Diabetes; DOMINANT DYSKERATOSIS-CONGENITA; STEM-CELL TRANSPLANTATION; BONE-MARROW FAILURE; REVERSE-TRANSCRIPTASE; TERMINAL TRANSFERASE; APLASTIC-ANEMIA; MUTATIONS; RNA; TETRAHYMENA; EMPHYSEMA;
D O I
10.1016/j.mrfmmm.2011.10.013
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is the most common manifestation of telomere-mediated disorders. Germline mutations in the essential telomerase genes, hTERT and hTR, are the causal genetic defect in up to one-sixth of pulmonary fibrosis families. The presence of telomerase mutations in this subset is significant for clinical decisions as affected individuals can develop extra-pulmonary complications related to telomere shortening such as bone marrow failure and cryptogenic liver cirrhosis. There is also evidence that IPF is an ancestral manifestation of autosomal dominant telomere syndromes where, with successive generations, the disease evolves from pulmonary fibrosis into a bone marrow failure-predominant disorder, defining a unique form of genetic anticipation. Here I review the significance of telomere defects for understanding the genetics, disease patterns and pathophysiology of IPF. The importance of this diagnosis for patient care decisions will also be discussed. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 50 条
  • [41] A Rare Missense Variant in Telomerase Reverse Transcriptase is Associated with Idiopathic Pulmonary Fibrosis in a Chinese Han Family
    Zheng, Chun-Ming
    Zhan, Xi
    Yang, Yuan-Hua
    Jiang, Tao
    Ye, Qiao
    Lug, Yong
    CHINESE MEDICAL JOURNAL, 2018, 131 (18) : 2205 - 2209
  • [42] Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Liu, Gabrielle Y.
    Budinger, G. R. Scott
    Dematte, Jane E.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [43] PATHOGENESIS OF IDIOPATHIC PULMONARY FIBROSIS
    BUHL, R
    MEIERSYDOW, J
    VOGELMEIER, C
    IMMUNITAT UND INFEKTION, 1995, 23 (03): : 92 - 96
  • [44] Pathogenesis of Idiopathic Pulmonary Fibrosis
    Wolters, Paul J.
    Collard, Harold R.
    Jones, Kirk D.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9, 2014, 9 : 157 - 179
  • [45] Update in idiopathic pulmonary fibrosis
    Frankel, Stephen K.
    Schwarz, Marvin I.
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (05) : 463 - 469
  • [46] Idiopathic pulmonary fibrosis in infants
    Osika, E
    Muller, MH
    BocconGibod, L
    Fauroux, B
    Sardet, A
    Grosskopf, C
    Couvreur, J
    Tournier, G
    Clement, A
    PEDIATRIC PULMONOLOGY, 1997, 23 (01) : 49 - 54
  • [47] Familial Idiopathic Pulmonary Fibrosis
    Wytrychowski, K.
    Hans-Wytrychowska, A.
    Nowakowska, B.
    NEUROBIOLOGY OF RESPIRATION, 2013, 788 : 363 - 367
  • [48] Cough in idiopathic pulmonary fibrosis
    van Manen, Mirjam J. G.
    Birring, Surinder S.
    Vancheri, Carlo
    Cottin, Vincent
    Renzoni, Elisabetta A.
    Russell, Anne-Marie
    Wijsenbeek, Marlies S.
    EUROPEAN RESPIRATORY REVIEW, 2016, 25 (141) : 278 - 286
  • [49] Cough in Idiopathic Pulmonary Fibrosis
    Mann, Jennifer
    Goh, Nicole S. L.
    Holland, Anne E.
    Khor, Yet Hong
    FRONTIERS IN REHABILITATION SCIENCES, 2021, 2
  • [50] Idiopathic Pulmonary Fibrosis and Telomeres
    Mulet, Alba
    Signes-Costa, Jaime
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)